Clinical Trials Browser

Neoplasms × Cryosurgery × 90 days × Clear all

NCT07629206 2026-06-05

Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)

Phase NA Not yet recruiting

Breast Neoplasms, Neoplasms